OPTIMIZATION OF MODERN TREATMENT TECHNOLOGY FOR PATIENTS WITH VITILIGO
Keywords:
Key words: Vitiligo, depigmentation, repigmentation, cytostatic, cytokine, UVB-therapy 311 nm.Abstract
Abstract. Vitiligo is the most common depigmentation disorder where the selective destruction of functioning melanocytes causes depigmentation of the skin, hair and mucosal surfaces. It affects approximately 0.5% to 1% of the population, with an average age of onset at about 24 years, its prevalence appears to be equal between men and women and there is no difference in the rate of occurrence according to skin type or race. Several etiological factors have been suggested for which the most compelling evidence involves a combination of environmental, genetic and immunological factors interacting to contribute to autoimmune melanocyte destruction. Vitiligo is a common skin disorder characterized by depigmented white patches in the skin due to loss of melanocytes.
References
Picardo M. Taiieb A: Vitiligo. Heidelberg: Springer; 2010. (Google Scholar)
Birlea SA, Spritz RA. Norris DA: Vitiligo Wolff K, editor. , ed. Fitzpatric's Dermatology in General Medicine 8th ed. New York: McGraw-Hill; in press.
Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their relatives. Pigment Cell Res. 2003;16:208–214.(PubMed) (Google Scholar)
Kyriakis KP, Palamaras I, Tsele E, Michailides C, Terzoudi S. Case detection rates of vitiligo by gender and age. Int J Dermatol. 2009;48:328–329.
Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: A comprehensive overview Part 1. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work up. J Am AcadDermatol. 2011;65:473–491.
Nabiyeva N. A. Diagnosis of children diagnosed with symptomatic epilepsy and cerebral palsy //european journal of modern medicine and practice. – 2022. – Т. 2. – №. 6. – С. 67-71.
Nordlund JJ, Ortonne J-P. Vitiligo Vulgaris. In: Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne J-P, editors. The Pigmentry System. New York: Oxford University Press; 1993. pp. 513–551. (Google Scholar)
Maxmudov, F. A., Raxmatov, O. B., Latipov, I. I., Rustamov, M. K., &Sharapova, G. S. (2021). Intravenous laser blood irradiation in the complex treatment of patients with cutaneous leishmaniasis. ), 48(9).
Latipov, I. I., Axmedovich, M. F., &Hamzao'g'li, O. J. (2021). Evaluation of the quality of life of vitiligo patients by the effectiveness of combination therapy using the dermatology life quality index (dlqi). Web of Scientist: International Scientific ResearchJournal, 2(10), 55-63.
Bakhadyr, A. (2015). Сharacteristics of the cellular immunity in HIV-infected patients with pyoderma. Europeansciencereview, (5-6).
Grimes PE, Morris R, Avaniss-Aghajani E, Soriano T, Meraz A. Topical tacrolimus therapy in vitiligo: Therapeutic responses and skin messenger RNA expression of proinflammatory cytokines. J Am AcadDermatol. 2004;51:52–61. (PubMed) (Google Scholar)
I.I. Latipov B.S. Azizov Assessment of the clinical efficacy of platelet rich plasma in vitiligo therapy/ Центральноазиатский научно- практический журнал. Новости дерматовенерологии и репродуктивного здаровья/ 1-2.2020 (89-90)
Li YL, Yu CL, Yu HS.IgG anti-melanocyte antibodies purified from patients with active vitiligo induce HLA-DR and intercellular adhesion molecule 1expression and increased IL-8 release by melanocytes. J Invest Dermatol. 2000;115:969–973. (PubMed) (Google Scholar)
Abdurahimovna N. N. Electroencephalography in the Diagnosis of Symptomatic Epilepsy in Patients with Infantial Cerebral Palsy //international journal of health systems and medical sciences. – 2022. – Т. 1. – №. 5. – С. 176-179.
Kim SM, Lee HS, Hann 5K. The efficacy of low-dose oral corticosteroids in the treatment of vitiligo patients.Int J Dermatol 1999; 38: 546-550
Njoo MD, Westerhof W, Bos JD. Development of guidelines for the treatment of vitiligo. Arch Dermatol 1999; 135: 1514-1521
Hikmatovna B. Z., Tukhtaeva K. K. Abu ali ibn sina about a healthy lifestyle //Academicia Globe: Inderscience Research. – 2021. – Т. 2. – №. 6. – С. 380-383.
Babajanova Z. K. The quality of clinical examination of patients with nerological diseases in family polyclinics // Asian journal of multidimensional research. – 2021. – Т. 10. – №. 4. – С. 1008-1012.
Latipov, I. I., Axmedovich, M. F., &Hamzao'g'li, O. J. (2021). Evaluation of the quality of life of vitiligo patients by the effectiveness of combination therapy using the dermatology life quality index (dlqi). Web of Scientist: International Scientific ResearchJournal, 2(10), 55-63.
